<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">338654</id>
  <title nil="true"/>
  <common-name>2-[(4-ethyl-5-pyrazin-2-yl-1,2,4-triazol-3-yl)sulfanyl]-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide</common-name>
  <description>2-[(4-ethyl-5-pyrazin-2-yl-1,2,4-triazol-3-yl)sulfanyl]-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide is a chemical compound with the formula C24H21N7OS2. It has an average molecular weight of 487.60 g/mol.</description>
  <cas>573945-36-5</cas>
  <pubchem-id>1864797</pubchem-id>
  <chemical-formula>C24H21N7OS2</chemical-formula>
  <weight>487.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T21:47:28Z</created-at>
  <updated-at type="dateTime">2026-08-30T21:47:28Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCN1C(=NN=C1SCC(=O)NC2=CC=C(C=C2)C3=NC4=C(S3)C=C(C=C4)C)C5=NC=CN=C5</moldb-smiles>
  <moldb-formula>C24H21N7OS2</moldb-formula>
  <moldb-inchi>InChI=1S/C24H21N7OS2/c1-3-31-22(19-13-25-10-11-26-19)29-30-24(31)33-14-21(32)27-17-7-5-16(6-8-17)23-28-18-9-4-15(2)12-20(18)34-23/h4-13H,3,14H2,1-2H3,(H,27,32)</moldb-inchi>
  <moldb-inchikey>BHWLXWLWPJRILH-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">487.1249007</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM334547</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[(4-ethyl-5-pyrazin-2-yl-1,2,4-triazol-3-yl)sulfanyl]-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzothiazoles</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0289081</sync-id>
  <structure-inchikey>BHWLXWLWPJRILH-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>204000000000800000000800000000002000000100000000001000000000000012000000000004000000002080000000000000000000000000000000000000000004000000000000000000000020000010000000000000000010000000000000210000000010200000100400840000000100000040020800000104000000000040010400004000000410200080880000008000000000000000000000000000000000000000000000080000000000000000490000000000002800000100000000000020001000000000000000040000000000002000000220010000000000008100000005002040000000000400020004010000004000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAC
AgdAKAAAAAMDBkAoAAAAAwQHQCgAAAADAwdAKAAAAAMDBkAoAAAAAwQQACAA
AAACBgBgAAAAAgIGACgAAAADBAgAKAAAAAMCBwBoAAAAAwIBBkAoAAAAAwQG
QGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA
KAAAAAMEB0AoAAAAAwMGQCgAAAADBAZAKAAAAAMEEEAoAAAAAwIGQGgAAAAD
AwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQYAYAAAAAEDBkAoAAAAAwQH
QCgAAAADAwZAaAAAAAMDAQZAaAAAAAMDAQdAKAAAAAMDBkBoAAAAAwMBCwAB
AAECAAIDaAwDBGgMBAVoDAUGaAwGBwAHCAAICQAJCigCCQsgCwwgDA1oDA0O
aAwOD2gMDxBoDBARaAwPEiASE2gMExRoDBQVaAwVFmgMFRdoDBcYaAwYGWgM
GRpoDBgbAAMcIBwdaAwdHmgMHh9oDB8gaAwgIWgMBgJoDBEMaAwWEmgMGhRo
DCEcaAxCBQAAAAUCAwQFBgYNDg8QEQwFExIWFRQGFxgZGhQVBh0eHyAhHBcE
AAAAAAAAABY=
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:21Z</structure-indexed-at>
</compound>
